Hungry for Gains? You Won't Believe The Secret Recipe Behind These Fat Dividends
As politicians cry "greedflation", savvy dividend investors are feasting on the food industry's cash payouts. While Senators slam pricing practices at McDonald's and Kroger's huge merger, smart money is capitalizing on this sector's unbeatable combination of:
Robust Cash Flows: Consumer staples leaders like Coca-Cola and PepsiCo generate gushing free cash flow thanks to phenomenal pricing power and dominant brands. That funds...
Rapidly Rising Dividends: PepsiCo has increased its payout an impressive 54% over the last 5 years, with more double-digit hikes on the menu. Hard to beat that income stream!
Buy and Hold This Dividend Stock Forever…and Leave It for Your Grandchildren
Consistent Share Buybacks: Mondelez has reduced its share count by 13% since 2018, directly boosting the value of each investor's stake. A capital return bonanza.
Recession-Resistant Business Models: Whether dining at McDonald's or loading up at Kroger, demand for value food options persists through economic cycles. Dependable dividend payments.
While candidates trade soundbites about "gouging", legendary food operators are dishing out hefty capital returns quarter after quarter. Their optimized pricing management, strategic mergers, and unmatched brand equity continue compounding value for income investors.
Ignore the political theater and use any dips to gobble up shares of these cash-flowing dividend aristocrats. With juicy yields up to 3.5%, sustained payout growth, and lucrative buybacks, your portfolio will be well-fed for years to come!
YOU NEED TO READ THIS NEXT
This Is By Far My #1 Income Stock
I am often asked what my favorite dividend stock is.
So I want to share the one single stock that's by far my favorite right now.
Unlike many dividend-paying companies... which rely on boring income through utilities, rent or oil...
This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year.
And it has a pipeline of other blockbuster drugs, which are expected to generate $35 billion in sales.
It doesn't take a genius to know that healthcare is at the forefront of everyone's mind right now, including the folks on Wall Street.
Last year, this company's stellar drug sales allowed it to pay shareholders $5.6 billion in dividends.
That's cash you can claim a piece of.
And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.
Sincerely,
Marc Lichtenfeld
Chief Income Strategist, The Oxford Club
P.S. When I say FREE, I mean it. There is no catch. You get my entire Ultimate Dividend Package... including my No. 1 dividend stock... free of charge. Here's how.